Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis
Chiodini Iacopo, Alberto Falchetti, Daniela Merlotti, et al.
Expert Review of Endocrinology & Metabolism (2020) Vol. 15, Iss. 4, pp. 283-298
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Riccardo Pofi, Giorgio Caratti, David Ray, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 975-1011
Closed Access | Times Cited: 68
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease
Edgar Wiebe, Dörte Huscher, Désirée Schaumburg, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 9, pp. 1313-1322
Open Access | Times Cited: 42
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Jérôme Bertherat, Isabelle Bourdeau, Lucas Bouys, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 4, pp. 567-628
Closed Access | Times Cited: 38
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, et al.
Journal of Bone and Mineral Metabolism (2024) Vol. 42, Iss. 2, pp. 143-154
Open Access | Times Cited: 11
A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease
Asim Rahman, Md. Faheem Haider
Steroids (2024) Vol. 207, pp. 109440-109440
Closed Access | Times Cited: 8
Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling
Gang Zheng, Haiwei Ma, Guangheng Xiang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review
Alessandro de Sire, Lorenzo Lippi, Vittorio Aprile, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 23
The Hidden Dangers of Plant-Based Diets Affecting Bone Health: A Cross-Sectional Study with U.S. National Health and Nutrition Examination Survey (NHANES) Data from 2005–2018
Yi Zheng, Jiacheng Wang, Yawen Wang, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1794-1794
Open Access | Times Cited: 14
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease
Stefano Frara, Agnese Allora, Luigi di Filippo, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 2, pp. 101515-101515
Closed Access | Times Cited: 32
Management of glucocorticoid-induced osteoporosis
Osvaldo Daniel Messina, Luis Vidal, Maritza Vidal, et al.
Aging Clinical and Experimental Research (2021) Vol. 33, Iss. 4, pp. 793-804
Closed Access | Times Cited: 30
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
Vittoria Favero, Arianna Cremaschi, Chiara Parazzoli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 673-673
Open Access | Times Cited: 19
Increased Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion
Vittoria Favero, Cristina Eller-Vainicher, Valentina Morelli, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 2, pp. e623-e632
Open Access | Times Cited: 12
Prevalence and Incidence of Fractures in Patients With Nonfunctional Adrenal Tumors
Jonatan D. Lindh, Jekaterina Patrova, Buster Mannheimer, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246453-e246453
Open Access | Times Cited: 4
Revolutionary Changes in the Management of Lupus Nephritis: Towards De-Glucocorticoid or No-Glucocorticoid
Yoshiya Tanaka
Drugs (2025)
Closed Access
Prevalence of MRONJ in patients treated with antiresorptive agents for glucocorticoid-induced osteoporosis
Hidenobu Sakuma, Hiroko Kanemaru, Akira Kurokawa, et al.
Oral and Maxillofacial Surgery (2025) Vol. 29, Iss. 1
Closed Access
Oxytocin and Bone: Review and Perspectives
Véronique Breuil, Marie-Charlotte Trojani, Ez‐Zoubir Amri
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8551-8551
Open Access | Times Cited: 25
Bone Fragility in Gastrointestinal Disorders
Daniela Merlotti, Christian Mingiano, Roberto Valenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2713-2713
Open Access | Times Cited: 17
Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management
Francesca Di Marcello, Giulia Di Donato, Debora Mariarita d’Angelo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5725-5725
Open Access | Times Cited: 16
Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know
L.C.P. Tavares, Lívia de Vasconcelos Nasser Caetano, Mayra Ianhez
Anais Brasileiros de Dermatologia (2023) Vol. 99, Iss. 2, pp. 259-268
Open Access | Times Cited: 9
Update on Glucocorticoid Induced Osteoporosis
Soo‐Kyung Cho, Yoon‐Kyoung Sung
Endocrinology and Metabolism (2021) Vol. 36, Iss. 3, pp. 536-543
Open Access | Times Cited: 23
Glucocorticoid-induced osteoporosis is prevented by dietary prune in female mice
Nicholas J. Chargo, Kerri A. Neugebauer, Douglas V. Guzior, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access | Times Cited: 2
Korean red ginseng extract prevents bone loss in an oral model of glucocorticoid induced osteoporosis in mice
Nicholas J. Chargo, Ho Jun Kang, Subhashari Das, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
Fabio Bioletto, M. Barale, Mirko Parasiliti‐Caprino, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials
Zhiming Liu, Min Zhang, Zhubin Shen, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243851-e0243851
Open Access | Times Cited: 13
Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis
Wanjun Li, Xi-le Wang, Yi-ran Chu, et al.
Clinical Rheumatology (2023) Vol. 43, Iss. 1, pp. 15-22
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top